These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7741013)

  • 1. In vivo brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in hepatic encephalopathy.
    Chamuleau RA; Vogels BA; Bosman DK; Bovée WM
    Adv Exp Med Biol; 1994; 368():23-31. PubMed ID: 7741013
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging and spectroscopy in hepatic encephalopathy.
    Gupta RK; Dhiman RK
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S45-9. PubMed ID: 15025255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scyllo-inositol depletion in hepatic encephalopathy.
    Lien YH; Michaelis T; Moats RA; Ross BD
    Life Sci; 1994; 54(20):1507-12. PubMed ID: 8190025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.
    Cudalbu C
    Metab Brain Dis; 2013 Jun; 28(2):167-74. PubMed ID: 23254563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.
    Grover VP; Dresner MA; Forton DM; Counsell S; Larkman DJ; Patel N; Thomas HC; Taylor-Robinson SD
    World J Gastroenterol; 2006 May; 12(19):2969-78. PubMed ID: 16718775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies.
    Butterworth RF
    J Hepatol; 2003 Aug; 39(2):278-85. PubMed ID: 12873828
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study.
    Poveda MJ; Bernabeu A; Concepción L; Roa E; de Madaria E; Zapater P; Pérez-Mateo M; Jover R
    Neuroimage; 2010 Aug; 52(2):481-7. PubMed ID: 20451628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure.
    Gupta RK; Saraswat VA; Poptani H; Dhiman RK; Kohli A; Gujral RB; Naik SR
    Am J Gastroenterol; 1993 May; 88(5):670-4. PubMed ID: 8480729
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Rackayova V; Braissant O; McLin VA; Berset C; Lanz B; Cudalbu C
    Metab Brain Dis; 2016 Dec; 31(6):1303-1314. PubMed ID: 26253240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy.
    Pujol J; Kulisevsky J; Moreno A; Deus J; Alonso J; Balanzó J; Martí-Vilalta JL; Capdevila A
    Neurology; 1996 Dec; 47(6):1526-30. PubMed ID: 8960739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy.
    McPhail MJ; Taylor-Robinson SD
    Metab Brain Dis; 2010 Mar; 25(1):65-72. PubMed ID: 20221679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neural activation following treatment of hepatic encephalopathy.
    McPhail MJ; Leech R; Grover VP; Fitzpatrick JA; Dhanjal NS; Crossey MM; Pflugrad H; Saxby BK; Wesnes K; Dresner MA; Waldman AD; Thomas HC; Taylor-Robinson SD
    Neurology; 2013 Mar; 80(11):1041-7. PubMed ID: 23427320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.
    Köstler H
    Metab Brain Dis; 1998 Dec; 13(4):291-301. PubMed ID: 10206821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of hepatic encephalopathy: will in vivo proton MRS play a role?
    Jalan R; Olde Damink SW; Hayes PC; Wardlaw JM
    Hepatology; 1999 May; 29(5):1605-7. PubMed ID: 10216150
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.
    Weissenborn K; Ahl B; Fischer-Wasels D; van den Hoff J; Hecker H; Burchert W; Köstler H
    Gut; 2007 Dec; 56(12):1736-42. PubMed ID: 17660226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy: A surrogate marker of hepatic encephalopathy?
    Hermann B; Rudler M; Galanaud D; Thabut D; Weiss N
    J Hepatol; 2019 Nov; 71(5):1055-1057. PubMed ID: 31500856
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodality magnetic resonance imaging in hepatic encephalopathy: an update.
    Zhang XD; Zhang LJ; Wu SY; Lu GM
    World J Gastroenterol; 2014 Aug; 20(32):11262-72. PubMed ID: 25170210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in cerebral inositols in rats and humans.
    Moats RA; Lien YH; Filippi D; Ross BD
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):15-8. PubMed ID: 8216210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton magnetic resonance spectroscopy for the evaluation of hepatic encephalopathy in dogs.
    Carrera I; Kircher PR; Meier D; Richter H; Beckman K; Dennler M
    Am J Vet Res; 2014 Sep; 75(9):818-27. PubMed ID: 25157885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase brain lactate in hepatic encephalopathy: cause or consequence?
    Rose CF
    Neurochem Int; 2010 Nov; 57(4):389-94. PubMed ID: 20600436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.